Neuronal dark matter: The emerging role of microRNAs in neurodegeneration

Frontiers in Cellular Neuroscience

Volumn , Issue OCT, 2013, Pages

  Goodall, Emily F ^a   Heath, Paul R ^a   Bandmann, Oliver ^a   Kirby, Janine ^a   Shaw, Pamela J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Huntington's disease; MicroRNA; Neurodegeneration; Parkinson's disease

Indexed keywords

ARGONAUTE PROTEIN; BETA SECRETASE 1; COPPER ZINC SUPEROXIDE DISMUTASE; LEVODOPA; MICRORNA; MICRORNA 106A; MICRORNA 106B; MICRORNA 107; MICRORNA 124A; MICRORNA 125B; MICRORNA 132; MICRORNA 133B; MICRORNA 146A; MICRORNA 150; MICRORNA 153; MICRORNA 181C; MICRORNA 184; MICRORNA 200A; MICRORNA 200C; MICRORNA 205; MICRORNA 206; MICRORNA 21; MICRORNA 224; MICRORNA 29; MICRORNA 34A; MICRORNA 9; RNA INDUCED SILENCING COMPLEX; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTOSIS; BRAIN DEPTH STIMULATION; DISEASE COURSE; DRUG RESPONSE; EXCITOTOXICITY; GENE REGULATORY NETWORK; GENE SILENCING; HUMAN; HUNTINGTON CHOREA; MOTONEURON; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; REVIEW; RNA GENE; RNA INTERFERENCE; RNA SEQUENCE; SPINAL MUSCULAR ATROPHY;

EID: 84886847678     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00178     Document Type: Review

References (152)

1. Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S., and van den Berg, L. H. (2012). The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 124, 339-352. doi: 10.1007/s00401-012-1022-4
2. Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Rodriguez-Oroz, M. C., Obeso, J. A., and Cooper, J. M. (2013). Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson's disease. Cell Death Dis. 4, e545. doi: 10.1038/cddis.2013.73
3. Asikainen, S., Rudgalvyte, M., Heikkinen, L., Louhiranta, K., Lakso, M., Wong, G., et al. (2010). Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models. J. Mol. Neurosci. 41, 210-218. doi: 10.1007/s12031-009-9325-1
4. Augustin, R., Endres, K., Reinhardt, S., Kuhn, P. H., Lichtenthaler, S. F., Hansen, J., et al. (2012). Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med. Genet. 13:35. doi: 10.1186/1471-2350-13-35
5. Avramopoulos, D. (2009). Genetics of Alzheimer's disease: recent advances. Genome Med. 1, 34. doi: 10.1186/gm34
6. Babiarz, J. E., Ruby, J. G., Wang, Y., Bartel, D. P., and Blelloch, R. (2008). Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev. 22, 2773-2785. doi: 10.1101/gad.1705308
7. Baccarini, A., Chauhan, H., Gardner, T. J., Jayaprakash, A. D., Sachidanandam, R., and Brown, B. D. (2011). Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Curr. Biol. 21, 369-376. doi: 10.1016/j.cub.2011.01.067
8. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell136, 215-233. doi: 10.1016/j.cell.2009.01.002
9. Berezikov, E., Chung, W. J., Willis, J., Cuppen, E., and Lai, E. C. (2007). Mammalian mirtron genes. Mol. Cell 28, 328-336. doi: 10.1016/j.molcel.2007.09.028
10. Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H., and Cuppen, E. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120, 21-24. doi: 10.1016/j.cell.2004.12.031
11. Bertram, L., Lill, C. M., and Tanzi, R. E. (2010). The genetics of Alzheimer disease: back to the future. Neuron 68, 270-281. doi: 10.1016/j.neuron.2010.10.013
12. Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., and Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23. doi: 10.1038/ng1934
13. Bettens, K., Brouwers, N., Engelborghs, S., Van Miegroet, H., De Deyn, P. P., Theuns, J., et al. (2009). APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Hum. Mutat. 30, 1207-1213. doi: 10.1002/humu.21027
14. Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I., and Filipowicz, W. (2006). Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125, 1111-1124. doi: 10.1016/j.cell.2006.04.031
15. Braak, H., and Braak, E. (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271-278. discussion: 278-284. doi: 10.1016/0197-4580(95)00021-6
16. Buratti, E., De Conti, L., Stuani, C., Romano, M., Baralle, M., and Baralle, F. (2010). Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 277, 2268-2281. doi: 10.1111/j.1742-4658.2010.07643.x
17. Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., et al. (2012). Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Invest. 122, 3063-3087. doi: 10.1172/JCI62636
18. Campos-Melo, D., Droppelmann, C. A., He, Z., Volkening, K., and Strong, M. J. (2013). Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol. Brain 6, 26. doi: 10.1186/1756-6606-6-26
19. Cardo, L. F., Coto, E., de Mena, L., Ribacoba, R., Moris, G., Menendez, M., et al. (2013). Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls. J. Neurol. 260, 1420-1422. doi: 10.1007/s00415-013-6900-8
20. Carthew, R. W., and Sontheimer, E. J. (2009). Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-655. doi: 10.1016/j.cell.2009.01.035.
21. Chatterjee, S., and Grosshans, H. (2009). Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 461, 546-549. doi: 10.1038/nature08349
22. Cheloufi, S., Dos Santos, C. O., Chong, M. M., and Hannon, G. J. (2010). A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465, 584-589. doi: 10.1038/nature09092
23. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006. doi: 10.1038/cr.2008.282
24. Cho, H. J., Liu, G., Jin, S. M., Parisiadou, L., Xie, C., Yu, J., et al. (2013). MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum. Mol. Genet. 22, 608-620. doi: 10.1093/hmg/dds470
25. Chuang, J. C., and Jones, P. A. (2007). Epigenetics and microRNAs. Pediatr. Res. 61, 24R-29R. doi: 10.1203/pdr.0b013e3180457684
26. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14, 27-41.
27. Conaco, C., Otto, S., Han, J. J., and Mandel, G. (2006). Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U.S.A. 103, 2422-2427. doi: 10.1073/pnas.0511041103
28. Coppede, F. (2012). Genetics and epigenetics of Parkinson's disease. ScientificWorldJournal 2012, 489830. doi: 10.1100/2012/489830
29. Czech, B., and Hannon, G. J. (2011). Small RNA sorting: matchmaking for Argonautes. Nat. Rev. Genet. 12, 19-31. doi: 10.1038/nrg2916
30. Dachsel, J. C., Taylor, J. P., Mok, S. S., Ross, O. A., Hinkle, K. M., Bailey, R. M., et al. (2007). Identification of potential protein interactors of Lrrk2. Parkinsonism Relat. Disord. 13, 382-385. doi: 10.1016/j.parkreldis.2007.01.008
31. De Felice, B., Guida, M., Coppola, C., De Mieri, G., and Cotrufo, R. (2012). A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 508, 35-40. doi: 10.1016/j.gene.2012.07.058
32. Delay, C., Mandemakers, W., and Hebert, S. S. (2012). MicroRNAs in Alzheimer's disease. Neurobiol. Dis. 46, 285-290. doi: 10.1016/j.nbd.2012.01.003
33. Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F., and Hannon, G. J. (2004). Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231-235. doi: 10.1038/nature03049
34. Diederichs, S., and Haber, D. A. (2007). Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131, 1097-1108. doi: 10.1016/j.cell.2007.10.032
35. Doxakis, E. (2010). Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J. Biol. Chem. 285, 12726-12734. doi: 10.1074/jbc.M109.086827
36. Ebert, M. S., and Sharp, P. A. (2010). MicroRNA sponges: progress and possibilities. RNA 16, 2043-2050. doi: 10.1261/rna.2414110
37. Ebert, M. S., and Sharp, P. A. (2012). Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515-524. doi: 10.1016/j.cell.2012.04.005
38. Elmen, J., Lindow, M., Schutz, S., Lawrence, M., Petri, A., Obad, S., et al. (2008). LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899. doi: 10.1038/nature06783
39. Ender, C., Krek, A., Friedlander, M. R., Beitzinger, M., Weinmann, L., Chen, W., et al. (2008). A human snoRNA with microRNA-like functions. Mol. Cell 32, 519-528. doi: 10.1016/j.molcel.2008.10.017
40. Etheridge, A., Lee, I., Hood, L., Galas, D., and Wang, K. (2011). Extracellular microRNA: a new source of biomarkers. Mutat. Res. 717, 85-90. doi: 10.1016/j.mrfmmm.2011.03.004
41. Fenn, A. M., Smith, K. M., Lovett-Racke, A. E., Guerau-de-Arellano, M., Whitacre, C. C., and Godbout, J. P. (2013). Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand. Neurobiol. Aging 34, 2748-2758. doi: 10.1016/j.neurobiolaging.2013.06.007
42. Friedman, R. C., Farh, K. K., Burge, C. B., and Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105. doi: 10.1101/gr.082701.108
43. Gaughwin, P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., and Bjorkqvist, M. (2011). Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum. Mol. Genet. 20, 2225-2237. doi: 10.1093/hmg/ddr111
44. Geekiyanage, H., Jicha, G. A., Nelson, P. T., and Chan, C. (2012). Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 235, 491-496. doi: 10.1016/j.expneurol.2011.11.026
45. Gehrke, S., Imai, Y., Sokol, N., and Lu, B. (2010). Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466, 637-641. doi: 10.1038/nature09191
46. Ghose, J., Sinha, M., Das, E., Jana, N. R., and Bhattacharyya, N. P. (2011). Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease. PLoS ONE 6:e23837. doi: 10.1371/journal.pone.0023837
47. Gonzalez-Alegre, P. (2007). Therapeutic RNA interference for neurodegenerative diseases: From promise to progress. Pharmacol. Ther. 114, 34-55. doi: 10.1016/j.pharmthera.2007.01.003
48. Goodall, E. F., Bury, J. J., Cooper-Knock, J., Shaw, P. J., and Kirby, J. (2012). "Genetics of familial amyotrophic lateral sclerosis, amyotrophic lateral sclerosis, " inAmyotrophic Lateral Sclerosis, ed M. H. Maurer (Rijeka: InTech), 517-536. doi: 10.5772/32498
49. Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., et al. (2004). The Microprocessor complex mediates the genesis of microRNAs. Nature432, 235-240. doi: 10.1038/nature03120
50. Griffiths-Jones, S., Saini, H. K., van Dongen, S., and Enright, A. J. (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res. 36, D154-D158. doi: 10.1093/nar/gkm952
51. Haramati, S., Chapnik, E., Sztainberg, Y., Eilam, R., Zwang, R., Gershoni, N., et al. (2010). miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. U.S.A. 107, 13111-13116. doi: 10.1073/pnas.1006151107
52. Hardy, J., Lewis, P., Revesz, T., Lees, A., and Paisan-Ruiz, C. (2009). The genetics of Parkinson's syndromes: a critical review. Curr. Opin. Genet. Dev. 19, 254-265. doi: 10.1016/j.gde.2009.03.008
53. Haussecker, D., Huang, Y., Lau, A., Parameswaran, P., Fire, A. Z., and Kay, M. A. (2010). Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA 16, 673-695. doi: 10.1261/rna.2000810
54. Hebert, S. S., Horre, K., Nicolai, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., et al. (2009). MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol. Dis. 33, 422-428. doi: 10.1016/j.nbd.2008.11.009
55. Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420. doi: 10.1073/pnas.0710263105
56. Heyer, M. P., Pani, A. K., Smeyne, R. J., Kenny, P. J., and Feng, G. (2012). Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice.J. Neurosci. 32, 10887-10894. doi: 10.1523/JNEUROSCI.1732-12.2012
57. Hwang, D. Y., Ardayfio, P., Kang, U. J., Semina, E. V., and Kim, K. S. (2003). Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res. Mol. Brain Res. 114, 123-131. doi: 10.1016/S0169-328X(03)00162-1
58. Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C. W., Saiki, S., Rose, C., et al. (2008). Huntington's disease: from pathology and genetics to potential therapies. Biochem. J. 412, 191-209. doi: 10.1042/BJ20071619
59. Itoh, N., and Ohta, H. (2013). Roles of FGF20 in dopaminergic neurons and Parkinson's disease. Front. Mol. Neurosci. 6:15. doi: 10.3389/fnmol.2013.00015
60. Jin, J., Cheng, Y., Zhang, Y., Wood, W., Peng, Q., Hutchison, E., et al. (2012). Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J. Neurochem. 123, 477-490. doi: 10.1111/j.1471-4159.2012.07925.x
61. Johnson, R., Zuccato, C., Belyaev, N. D., Guest, D. J., Cattaneo, E., and Buckley, N. J. (2008). A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 29, 438-445. doi: 10.1016/j.nbd.2007.11.001
62. Junn, E., Lee, K. W., Jeong, B. S., Chan, T. W., Im, J. Y., and Mouradian, M. M. (2009). Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl. Acad. Sci. U.S.A. 106, 13052-13057. doi: 10.1073/pnas.0906277106
63. Kapranov, P., and St Laurent, G. (2012). Dark matter RNA: existence, function, and controversy. Front. Genet. 3:60. doi: 10.3389/fgene.2012.00060
64. Kawahara, Y., and Mieda-Sato, A. (2012). TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. U.S.A. 109, 3347-3352. doi: 10.1073/pnas.1112427109
65. Khan, A. A., Betel, D., Miller, M. L., Sander, C., Leslie, C. S., and Marks, D. S. (2009). Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 27, 549-555. doi: 10.1038/nbt.1543
66. Khoo, S. K., Petillo, D., Kang, U. J., Resau, J. H., Berryhill, B., Linder, J., et al. (2012). Plasma-based circulating MicroRNA biomarkers for parkinson's disease. J. Parkinsons Dis. 2, 321-331. doi: 10.3233/JPD-012144
67. Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., et al. (2007). A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224. doi: 10.1126/science.1140481
68. Kim, J., Yoon, H., Ramirez, C. M., Lee, S. M., Hoe, H. S., and Fernandez-Hernando, C. (2012). MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp. Neurol. 235, 476-483. doi: 10.1016/j.expneurol.2011.11.010
69. Kim, Y. K., and Kim, V. N. (2007). Processing of intronic microRNAs. EMBO J. 26, 775-783. doi: 10.1038/sj.emboj.7601512
70. Koval, E. D., Shaner, C., Zhang, P., du Maine, X., Fischer, K., Tay, J., et al. (2013). Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet. 22, 4127-4135. doi: 10.1093/hmg/ddt261
71. Krek, A., Grun, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., et al. (2005). Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500. doi: 10.1038/ng1536
72. Krol, J., Busskamp, V., Markiewicz, I., Stadler, M. B., Ribi, S., Richter, J., et al. (2010a). Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 141, 618-631. doi: 10.1016/j.cell.2010.03.039
73. Krol, J., Loedige, I., and Filipowicz, W. (2010b). The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610. doi: 10.1038/nrg2843
74. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., and Tuschl, T. (2002). Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739. doi: 10.1016/S0960-9822(02)00809-6
75. Lee, S. T., Chu, K., Im, W. S., Yoon, H. J., Im, J. Y., Park, J. E., et al. (2011). Altered microRNA regulation in Huntington's disease models. Exp. Neurol. 227, 172-179. doi: 10.1016/j.expneurol.2010.10.012
76. Lee, Y., Jeon, K., Lee, J. T., Kim, S., and Kim, V. N. (2002). MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670. doi: 10.1093/emboj/cdf476
77. Lee, Y. S., Shibata, Y., Malhotra, A., and Dutta, A. (2009). A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 23, 2639-2649. doi: 10.1101/gad.1837609
78. Lehmann, S. M., Kruger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., et al. (2012). An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15, 827-835. doi: 10.1038/nn.3113
79. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20. doi: 10.1016/j.cell.2004.12.035
80. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P., and Burge, C. B. (2003). Prediction of mammalian microRNA targets. Cell 115, 787-798. doi: 10.1016/S0092-8674(03)01018-3
81. Li, Y. Y., Cui, J. G., Dua, P., Pogue, A. I., Bhattacharjee, S., and Lukiw, W. J. (2011). Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci. Lett. 499, 109-113. doi: 10.1016/j.neulet.2011.05.044
82. Liang, C., Zhu, H., Xu, Y., Huang, L., Ma, C., Deng, W., et al. (2012). MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res. 1455, 103-113. doi: 10.1016/j.brainres.2011.10.051
83. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773. doi: 10.1038/nature03315
84. Ling, S., Zhou, J., Rudd, J. A., Hu, Z., and Fang, M. (2011). The recent updates of therapeutic approaches against abeta for the treatment of Alzheimer's disease. Anat. Rec. (Hoboken) 294, 1307-1318. doi: 10.1002/ar.21425
85. Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J. J., et al. (2004). Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437-1441. doi: 10.1126/science.1102513
86. Liu, N., Landreh, M., Cao, K., Abe, M., Hendriks, G. J., Kennerdell, J. R., et al. (2012). The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482, 519-523. doi: 10.1038/nature10810
87. Liu, Q., Xie, F., Alvarado-Diaz, A., Smith, M. A., Moreira, P. I., Zhu, X., et al. (2011). Neurofilamentopathy in neurodegenerative diseases. Open Neurol. J. 5, 58-62. doi: 10.2174/1874205X01105010058
88. Long, J. M., Ray, B., and Lahiri, D. K. (2012). MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J. Biol. Chem. 287, 31298-31310. doi: 10.1074/jbc.M112.366336
89. Lukiw, W. J., Zhao, Y., and Cui, J. G. (2008). An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 283, 31315-31322. doi: 10.1074/jbc.M805371200
90. Margis, R., and Rieder, C. R. (2011). Identification of blood microRNAs associated to Parkinson's disease. J. Biotechnol. 152, 96-101. doi: 10.1016/j.jbiotec.2011.01.023
91. Marti, E., Pantano, L., Banez-Coronel, M., Llorens, F., Minones-Moyano, E., Porta, S., et al. (2010). A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 38, 7219-7235. doi: 10.1093/nar/gkq575
92. Martins, M., Rosa, A., Guedes, L. C., Fonseca, B. V., Gotovac, K., Violante, S., et al. (2011). Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson's disease. PLoS ONE 6:e25443. doi: 10.1371/journal.pone.0025443
93. Mattick, J. S. (2005). The functional genomics of noncoding RNA. Science 309, 1527-1528. doi: 10.1126/science.1117806
94. McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Monteys, A. M., Martins, I., et al. (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. U.S.A. 105, 5868-5873. doi: 10.1073/pnas.0801775105
95. McCarthy, J. J. (2008). MicroRNA-206: the skeletal muscle-specific myomiR. Biochim. Biophys. Acta 1779, 682-691. doi: 10.1016/j.bbagrm.2008.03.001
96. McDermott, C. J., and Shaw, P. J. (2008). Diagnosis and management of motor neurone disease. BMJ 336, 658-662. doi: 10.1136/bmj.39493.511759.BE
97. Minones-Moyano, E., Porta, S., Escaramis, G., Rabionet, R., Iraola, S., Kagerbauer, B., et al. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078. doi: 10.1093/hmg/ddr210
98. Miyoshi, K., Miyoshi, T., and Siomi, H. (2010). Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Mol. Genet. Genomics. 284, 95-103. doi: 10.1007/s00438-010-0556-1
99. Morel, L., Regan, M., Higashimori, H., Ng, S. K., Esau, C., Vidensky, S., et al. (2013). Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J. Biol. Chem. 288, 7105-7116. doi: 10.1074/jbc.M112.410944
100. Morlando, M., Dini Modigliani, S., Torrelli, G., Rosa, A., Di Carlo, V., Caffarelli, E., et al. (2012). FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 31, 4502-4510. doi: 10.1038/emboj.2012.319
101. Nana-Sinkam, S. P., and Croce, C. M. (2013). Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 93, 98-104. doi: 10.1038/clpt.2012.192
102. Nelson, P. T., and Wang, W. X. (2010). MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J. Alzheimers Dis. 21, 75-79. doi: 10.3233/JAD-2010-091603
103. Nissan, X., Blondel, S., Navarro, C., Maury, Y., Denis, C., Girard, M., et al. (2012). Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep. 2, 1-9. doi: 10.1016/j.celrep.2012.05.015
104. Orom, U. A., Nielsen, F. C., and Lund, A. H. (2008). MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 30, 460-471. doi: 10.1016/j.molcel.2008.05.001
105. Ozsolak, F., Poling, L. L., Wang, Z., Liu, H., Liu, X. S., Roeder, R. G., et al. (2008). Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172-3183. doi: 10.1101/gad.1706508
106. Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., and Davidson, B. L. (2008). The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 28, 14341-14346. doi: 10.1523/JNEUROSCI.2390-08.2008
107. Patel, N., Hoang, D., Miller, N., Ansaloni, S., Huang, Q., Rogers, J. T., et al. (2008). MicroRNAs can regulate human APP levels. Mol. Neurodegener. 3:10. doi: 10.1186/1750-1326-3-10
108. Pratt, A. J., and MacRae, I. J. (2009). The RNA-induced silencing complex: a versatile gene-silencing machine. J. Biol. Chem. 284, 17897-17901. doi: 10.1074/jbc.R900012200
109. Ramachandran, V., and Chen, X. (2008). Degradation of microRNAs by a family of exoribonucleases in Arabidopsis. Science 321, 1490-1492. doi: 10.1126/science.1163728
110. Raposo, G., and Stoorvogel, W. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383. doi: 10.1083/jcb.201211138
111. Robberecht, W., and Philips, T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248-264. doi: 10.1038/nrn3430
112. Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L., and Bradley, A. (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902-1910. doi: 10.1101/gr.2722704
113. Ruby, J. G., Jan, C. H., and Bartel, D. P. (2007). Intronic microRNA precursors that bypass Drosha processing. Nature 448, 83-86. doi: 10.1038/nature05983
114. Russell, A. P., Wada, S., Vergani, L., Hock, M. B., Lamon, S., Leger, B., et al. (2012). Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol. Dis. 49C, 107-117. doi: 10.1016/j.nbd.2012.08.015
115. Salmena, L., Poliseno, L., Tay, Y., Kats, L., and Pandolfi, P. P. (2011). A ceRNA hypothesis: the rosetta stone of a hidden RNA language. Cell 146, 353-358. doi: 10.1016/j.cell.2011.07.014
116. Saraiya, A. A., and Wang, C. C. (2008). snoRNA, a novel precursor of microRNA in Giardia lamblia. PLoS Pathog. 4:e1000224. doi: 10.1371/journal.ppat.1000224
117. Saunders, L. R., Sharma, A. D., Tawney, J., Nakagawa, M., Okita, K., Yamanaka, S., et al. (2010). miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) 2, 415-431.
118. Savas, J. N., Makusky, A., Ottosen, S., Baillat, D., Then, F., Krainc, D., et al. (2008). Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc. Natl. Acad. Sci. U.S.A. 105, 10820-10825. doi: 10.1073/pnas.0800658105
119. Schipper, H. M., Maes, O. C., Chertkow, H. M., and Wang, E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Biol. 1, 263-274.
120. Schmitt, I., Wullner, U., van Rooyen, J. P., Khazneh, H., Becker, J., Volk, A., et al. (2012). Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression. Eur. J. Hum. Genet. 20, 1265-1269. doi: 10.1038/ejhg.2012.84
121. Schonrock, N., and Gotz, J. (2012). Decoding the non-coding RNAs in Alzheimer's disease. Cell. Mol. Life Sci. 69, 3543-3559. doi: 10.1007/s00018-012-1125-z
122. Schonrock, N., Humphreys, D. T., Preiss, T., and Gotz, J. (2012). Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta. J. Mol. Neurosci. 46, 324-335. doi: 10.1007/s12031-011-9587-2
123. Schonrock, N., Ke, Y. D., Humphreys, D., Staufenbiel, M., Ittner, L. M., Preiss, T., et al. (2010). Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS ONE 5:e11070. doi: 10.1371/journal.pone.0011070
124. Seredenina, T., and Luthi-Carter, R. (2012). What have we learned from gene expression profiles in Huntington's disease. Neurobiol. Dis. 45, 83-98. doi: 10.1016/j.nbd.2011.07.001
125. Sethi, P., and Lukiw, W. J. (2009). Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett. 459, 100-104. doi: 10.1016/j.neulet.2009.04.052
126. Shaked, I., Meerson, A., Wolf, Y., Avni, R., Greenberg, D., Gilboa-Geffen, A., et al. (2009). MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31, 965-973. doi: 10.1016/j.immuni.2009.09.019
127. Shi, M., Caudle, W. M., and Zhang, J. (2009). Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol. Dis. 35, 157-164. doi: 10.1016/j.nbd.2008.09.004
128. Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T., et al. (2010). Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 36, 320-330. doi: 10.1111/j.1365-2990.2010.01076.x
129. Sibley, C. R., Seow, Y., Curtis, H., Weinberg, M. S., and Wood, M. J. (2012). Silencing of Parkinson's disease-associated genes with artificial mirtron mimics of miR-1224. Nucleic Acids Res. 40, 9863-9875. doi: 10.1093/nar/gks712
130. Sinha, M., Ghose, J., and Bhattarcharyya, N. P. (2011). Micro RNA-214,-150,-146a and-125b target Huntingtin gene. RNA Biol. 8, 1005-1021. doi: 10.4161/rna.8.6.16035
131. Sinha, M., Ghose, J., Das, E., and Bhattarcharyya, N. P. (2010). Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP. Biochem. Biophys. Res. Commun. 396, 742-747. doi: 10.1016/j.bbrc.2010.05.007
132. Smith, P., Al Hashimi, A., Girard, J., Delay, C., and Hebert, S. S. (2011). In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J. Neurochem. 116, 240-247. doi: 10.1111/j.1471-4159.2010.07097.x
133. Soreq, H., and Wolf, Y. (2011). NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol. Med. 17, 548-555. doi: 10.1016/j.molmed.2011.06.009
134. Soreq, L., Salomonis, N., Bronstein, M., Greenberg, D. S., Israel, Z., Bergman, H., et al. (2013). Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front. Mol. Neurosci. 6:10. doi: 10.3389/fnmol.2013.00010
135. Sotiriou, S., Gibney, G., Baxevanis, A. D., and Nussbaum, R. L. (2009). A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease. Neurosci. Lett. 461, 196-201. doi: 10.1016/j.neulet.2009.06.034
136. Tang, G., Tang, X., Mendu, V., Jia, X., Chen, Q. J., and He, L. (2008). The art of microRNA: various strategies leading to gene silencing via an ancient pathway. Biochim. Biophys. Acta 1779, 655-662. doi: 10.1016/j.bbagrm.2008.06.006
137. Tanzi, R. E. (2012). The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, 6296-6306. doi: 10.1101/cshperspect.a006296
138. Vasudevan, S., Tong, Y., and Steitz, J. A. (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934. doi: 10.1126/science.1149460
139. Villa, C., Ridolfi, E., Fenoglio, C., Ghezzi, L., Vimercati, R., Clerici, F., et al. (2013). Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. J. Alzheimers Dis. 35, 487-494. doi: 10.3233/JAD-122263
140. Wanet, A., Tacheny, A., Arnould, T., and Renard, P. (2012). miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res. 40, 4742-4753. doi: 10.1093/nar/gks151
141. Wang, G., van der Walt, J. M., Mayhew, G., Li, Y. J., Zuchner, S., Scott, W. K., et al. (2008a). Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 82, 283-289. doi: 10.1016/j.ajhg.2007.09.021
142. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., et al. (2008b). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223. doi: 10.1523/JNEUROSCI.5065-07.2008
143. Wang, L. L., Huang, Y., Wang, G., and Chen, S. D. (2012). The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target. Med. Hypotheses 78, 398-401. doi: 10.1016/j.mehy.2011.11.019
144. Wang, W. X., Huang, Q., Hu, Y., Stromberg, A. J., and Nelson, P. T. (2011). Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 121, 193-205. doi: 10.1007/s00401-010-0756-0
145. Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., et al. (2009). miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 80, 268-273. doi: 10.1016/j.brainresbull.2009.08.006
146. Williams, A. H., Valdez, G., Moresi, V., Qi, X., McAnally, J., Elliott, J. L., et al. (2009). MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554. doi: 10.1126/science.1181046
147. Winslow, A. R., and Rubinsztein, D. C. (2011). The Parkinson disease protein alpha-synuclein inhibits autophagy. Autophagy 7, 429-431. doi: 10.4161/auto.7.4.14393
148. Wong, H. K., Veremeyko, T., Patel, N., Lemere, C. A., Walsh, D. M., Esau, C., et al. (2013). De-repression of FOXO3a death axis by microRNA-132 and-212 causes neuronal apoptosis in Alzheimer's disease. Hum. Mol. Genet. 22, 3077-3092. doi: 10.1093/hmg/ddt164
149. Zhou, X., Ruan, J., Wang, G., and Zhang, W. (2007). Characterization and identification of microRNA core promoters in four model species. PLoS Comput. Biol. 3:e37. doi: 10.1371/journal.pcbi.0030037
150. Zong, Y., Wang, H., Dong, W., Quan, X., Zhu, H., Xu, Y., et al. (2011). miR-29c regulates BACE1 protein expression. Brain Res. 1395, 108-115. doi: 10.1016/j.brainres.2011.04.035
151. Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., et al. (2007). Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 27, 6972-6983. doi: 10.1523/JNEUROSCI.4278-06.2007
152. Zuccato, C., Valenza, M., and Cattaneo, E. (2010). Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol. Rev. 90, 905-981. doi: 10.1152/physrev.00041.2009